[高风险急性髓性白血病的治疗]
1Department of Blood Transfusion, The University of Tokyo Hospital.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|November 5, 2025
概括
急性髓性白血病 (AML) 是老年人的一种复杂癌症. 新的治疗方法提供了希望,但高风险的AML仍然需要更好的治疗策略和研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 急性髓性白血病 (AML) 不成比例地影响老年人,其特点是遗传异质性.
- 风险因素包括染色体异常,先前的血液学疾病,以及暴露于细胞毒剂或辐射,导致二次AML.
- 像"7+3"疗法这样的传统治疗方法正在被新的选择所补充.
研究的目的:
- 审查目前高风险急性髓性白血病的治疗选择.
- 讨论挑战性AML病例的未来治疗前景.
- 解决AML管理的未满足需求,特别是老年患者.
主要方法:
- 审查目前的AML治疗格局.
- 对新型治疗方案的分析,包括阿扎西蒂丁,维内托克拉克斯,CPX-351和quizartinib.
- 对高风险AML亚型的治疗结果的评估.
主要成果:
- 对AML的治疗选择已经扩大到传统化疗之外.
- 新的药物,如阿扎西蒂丁与venetoclax和组合化疗,显示出有希望的结果.
- 尽管有进展,但高风险AML和二次AML存在重大挑战,治愈率有限.
结论:
- 虽然新型疗法改善了AML治疗,但高风险疾病仍然难以治愈.
- 进一步的研究是必不可少的,以制定更有效的策略来治疗预后不良的AML.
- 解决遗传异质AML的复杂性对于改善患者的治疗结果至关重要.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.6K
相关概念视频
Bone Marrow Sampling and Transplants
858
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
858
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
